1. Epstein-Barr virus (EBV)–associated lymphoid proliferations, a 2018 update
   Sherif A. Rezk et al, 2018, Human Pathology CrossRef
2. Epigenetic aberrations in natural killer/T-cell lymphoma: diagnostic, prognostic and therapeutic implications
   Can Küçük et al, 2020, Therapeutic Advances in Medical Oncology CrossRef
3. Non-coding RNAs in Natural Killer/T-Cell Lymphoma
   Mei Mei et al, 2019, Frontiers in Oncology CrossRef
4. Genomic and transcriptomic landscapes of Epstein-Barr virus in extranodal natural killer T-cell lymphoma
   Rou-Jun Peng et al, 2019, Leukemia CrossRef
5. Rational Targets of Therapy in Extranodal NK/T-Cell Lymphoma
   Ajay Major et al, 2023, Cancers CrossRef
6. Epstein-Barr Virus-Positive Natural Killer/T-Cell Lymphoma
   Qingqing Cai et al, 2019, Frontiers in Oncology CrossRef
7. The landscape of new drugs in extranodal NK/T-cell lymphoma
   Liang Wang et al, 2020, Cancer Treatment Reviews CrossRef
8. Novel target and treatment agents for natural killer/T-cell lymphoma
   Xiao-Peng Tian et al, 2023, Journal of Hematology & Oncology CrossRef
9. The identification of gene signatures in patients with extranodal NK/T-cell lymphoma from a pair of twins
   Yang Wang et al, 2021, BMC Cancer CrossRef
10. Chidamide Induces Epstein-Barr Virus (EBV) Lytic Infection and Acts Synergistically with Tenofovir to Eliminate EBV-Positive Burkitt Lymphoma
    Linyan Xu et al, 2023, Journal of Pharmacology and Experimental Therapeutics CrossRef
11. Introduction of Genetically Modified CD3ζ Improves Proliferation and Persistence of Antigen-Specific CTLs
    Kotaro Miyao et al, 2018, Cancer Immunology Research CrossRef
12. New developments in the pathology of malignant lymphoma. A review of the literature published from September 2015–December 2015
    J. Han van Krieken, 2016, Journal of Hematopathology CrossRef
13. EBV–Associated Lymphoproliferative Disorders
    Sherif A. Rezk et al, 2019, Surgical Pathology Clinics CrossRef
14. EBV and Lymphomagenesis
    Daniel G. Sausen et al, 2023, Cancers CrossRef
15. Eukaryotic initiating factor eIF4E is targeted by EBV-encoded miR-BART11-3p and regulates cell cycle and apoptosis in EBV-associated gastric carcinoma
    Hanqing Wang et al, 2021, Virus Genes CrossRef
16. A neutralized human LMP1-IgG inhibits ENKTL growth by suppressing the JAK3/STAT3 signaling pathway
    Yuan Mao et al, 2017, Oncotarget CrossRef